RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Effect of regorafenib in delaying definitive deterioration in health-related quality of life across three tumor types

Hofheinz, R., Marian, M., Bartsch, J., & Odom, D. (2019). Effect of regorafenib in delaying definitive deterioration in health-related quality of life across three tumor types. Annals of Oncology, 30(Suppl 4), iv37. https://doi.org/10.1093/annonc/mdz155.135

10.1093/annonc/mdz155.135

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

Navigate to Dawn Odom

Dawn Odom